GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: QY-201 | QY201 | VVN-461 | VVN461
Compound class:
Synthetic organic
Comment: Quecitinib is the INN for a Janus kinase inhibitor with anti-inflammatory potential (INN proposed list 133, 10th July 2025). We have mapped this to the disclosed structure of clinical lead QY201, which is declared as an orally administered dual JAK1/TYK2 inhibitor [1]. The structure also matches the compound named VVN461 in patent WO2024221524A1 [2].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13597 | quecitinib |
Synonyms ![]() |
| QY-201 | QY201 | VVN-461 | VVN461 |
Database Links ![]() |
|
| CAS Registry No. | 2416858-84-7 (source: WHO INN record) |
| GtoPdb PubChem SID | 518520691 |
| PubChem CID | 156188109 |
| Search Google for chemical match using the InChIKey | LUQHXRXPKKQUKV-LLVKDONJSA-N |
| Search Google for chemicals with the same backbone | LUQHXRXPKKQUKV |
| Search PubMed clinical trials | quecitinib |
| Search PubMed titles | quecitinib |
| Search PubMed titles/abstracts | quecitinib |
| UniChem Compound Search for chemical match using the InChIKey | LUQHXRXPKKQUKV-LLVKDONJSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | LUQHXRXPKKQUKV-LLVKDONJSA-N |